Smart Immune and Greater Paris University Hospitals (AP-HP) begin groundbreaking Phase I/II trial with ProTcellTM, a thymus-empowered T-cell therapy platform, in adults with blood cancers

View Larger Image

Smart Immune supported by MATWIN in 2022 and awarded “ Best Therapeutic Innovation” by MATWIN International Board launches a Phase I/II trial in adults with blood cancers

Download the press release :

stephanie.dhont2023-01-17T15:31:41+01:00